filmov
tv
Emerging Data in EGFR-Mutant Lung Cancer
Показать описание
Benjamin P. Levy, MD, and Luis E. Raez, MD, review promising strategies in non–small cell lung cancer, including the potential for osimertinib to be used in the frontline.
OncLive
cancer
oncology
Рекомендации по теме
0:07:08
Emerging Data in EGFR-Mutant Lung Cancer
0:37:44
Deciphering the data in EGFR - Mutant NSCLC
0:01:01
Dr. Shum on Emerging Targeted Therapies in EGFR-Mutant NSCLC
0:01:41
IMpower150 Data for Immunotherapy Quadruplet in EGFR-Mutant Lung Cancer
0:00:59
Dr. West on Emerging Changes in the Field of EGFR-Mutant NSCLC
0:58:47
15 Years of Advances in EGFR Mutant Lung Cancer
0:30:32
2023 Best of Lung: Targeted Therapies in Lung Cancer
0:13:26
DEBATE: Drug of choice for exon 19 del EGFR mutant NSCLC - Any EGFR TKI
2:49:16
PhD café - A virtual seminar series for PhD researchers in India - Molecular Biology
0:06:02
Q & A with EGFR-Mutant Lung Cancer Experts | 2024 Living with EGFR-Mutant Lung Cancer Patient Fo...
1:02:40
New Milestones and Changing Standards of Care in Early EGFR-Mutated NSCLC
0:01:25
Current treatment recommendations and future directions for EGFR-mutant NSCLC
0:16:22
DEBATE: Drug of choice for exon 19 del EGFR mutant NSCLC - Afatinib
0:04:25
Do immune checkpoint inhibitors work in EGFR mutant lung cancer?
0:00:48
New standard of care for lung cancer patients with EGFR mutations
1:05:12
New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testing
0:00:50
Treating Patients With EGFR-Mutant Lung Cancer With Targeted Therapies
1:18:11
Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases
0:14:24
EGFR-Mutant Lung Cancer & Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient F...
0:03:38
Overview of the world of EGFR mutant lung cancers
0:20:35
TKI-resistant EGFR-mutant NSCLC
0:14:23
Treatment Updates: EGFR-Mutant Lung Cancer | 2024 Living with EGFR-Mutant Lung Cancer Patient Forum
0:58:24
Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC
0:14:30
Adjuvant therapy for EGFR mutant NSCLC